FdaApplication
NDA 216974
Identifiers
- fda_app_no: NDA216974
Properties
| Property | Value |
|---|---|
| applicant_name | ENTASIS THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2023-05-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XACDURO (COPACKAGED) | DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM | EQ 500MG BASE/VIAL;EQ 500MG BASE/VIAL;EQ 1GM BASE/VIAL | POWDER;INTRAVENOUS |
1 product